The innovation and technology leader in sinus dressings. PosiSep X BAM incorporates Hemostasis’ shellfish-free BioNOCC chitosan with two water-soluble and mobile antimicrobials to bring the next generation of sinus dressings to the ENT market.  

BAM is a groundbreaking advancement in the sinus dressings market. Hemostasis first revolutionized sinus care in 2011 with the launch of PosiSep, utilizing cutting-edge chitosan technology. Since then, we have continuously pursued innovating, introducing NOCC anti-adhesion technology in 2016, along with a compressed, shape-memory wafer design that enhances ease of use and sets a new standard for sinus dressings.

Following this, we proudly introduced BioNOCC, the world’s first American-made non-shellfish chitosan sinus dressing, expanding our commitment to safety and efficacy.

BAM elevates our innovative journey even further by incorporating two effective antimicrobial agents, providing protection against gram-positive and gram-negative bacteria, as well as fungi. Experience the next level of sinus dressing technology with PosiSep X BAM.

For detailed information regarding indications for use, warnings and precautions, see Instructions for Use.

• Dual Antimicrobial Protection: Formulated with methylene blue and Gentian Violet, both mobile and water-soluble agents, to enhance efficacy.
• Exceptional Antimicrobial Efficacy: Achieves over 4-log reduction against gram-positive and gram-negative bacteria and fungi, ensuring more than 99.99% efficacy.
• Innovative BioNOCC and Antimicrobial Technology: Integrates advanced BioNOCC with powerful antimicrobial properties for superior performance.
• Versatile Sizing Options: Available in multiple sizes to cater to various surgical applications and patient needs.
• Anatomical Conformity: Specifically designed to conform to individual anatomy, ensuring optimal placement and stability during use.  
• Effortless Debridement: Enables quick and easy debridement as BAM effortlessly suctions away.